This study aimed to explore whether rapamycin inhibits the activation of NLRP3-dependent pyroptosis by regulating mTOR, to reduce OSA-related renal injury, and to provide a new basis for the diagnosis and treatment of OSA-related renal injury. Here, NLRP3 is linked to obstructive sleep apnea syndrome.